BDNF and Alzheimer disease: As evidence suggested that Aβ reduced BDNF expression mostly by decreasing the levels of pCREB protein, targeting of the CREB/BDNF pathway against Aβ toxicity was considered a beneficial approach to improving AD behaviors [54].